Vidarabine

阿糖腺苷

Report date: 2022/03/01 14:18:09
NME

Base Information

Drug NameVidarabine
Drug Alias Name腺嘌呤阿糖苷vidarabinaVidarabinumArasena-AVira-A +[7] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsHerpes Zoster
Global Approved IndicationsHerpes Zoster
Approved Indications in ChinaHerpes Zoster
Original Approved Country/TerritoryUnited States
Original Approved Date1976/11/26
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesParkedale Pharmaceuticals, Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Longfu Medicine Co Ltd
Inactive CompaniesParkedale Pharmaceuticals, Inc
Active IndicationsHerpes Zoster
Inactive IndicationsN/A

Other Information

ATC CodeJ05AB03S01AD06
Related LinksWikipediaDrugBankKEGG